Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.
Gulyas M, Mattsson JSM, Lindgren A, Ek L, Lamberg Lundström K, Behndig A, Holmberg E, Micke P, Bergman B; Swedish Lung Cancer Study Group. Gulyas M, et al. Acta Oncol. 2018 Feb;57(2):244-250. doi: 10.1080/0284186X.2017.1400685. Epub 2017 Nov 15. Acta Oncol. 2018. PMID: 29140138 Clinical Trial.
Profiling cancer testis antigens in non-small-cell lung cancer.
Djureinovic D, Hallström BM, Horie M, Mattsson JSM, La Fleur L, Fagerberg L, Brunnström H, Lindskog C, Madjar K, Rahnenführer J, Ekman S, Ståhle E, Koyi H, Brandén E, Edlund K, Hengstler JG, Lambe M, Saito A, Botling J, Pontén F, Uhlén M, Micke P. Djureinovic D, et al. JCI Insight. 2016 Jul 7;1(10):e86837. doi: 10.1172/jci.insight.86837. JCI Insight. 2016. PMID: 27699219 Free PMC article.
The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
Micke P, Mattsson JS, Djureinovic D, Nodin B, Jirström K, Tran L, Jönsson P, Planck M, Botling J, Brunnström H. Micke P, et al. J Thorac Oncol. 2016 Jun;11(6):862-72. doi: 10.1016/j.jtho.2016.01.020. Epub 2016 Feb 9. J Thorac Oncol. 2016. PMID: 26872818
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer.
Noguchi S, Saito A, Horie M, Mikami Y, Suzuki HI, Morishita Y, Ohshima M, Abiko Y, Mattsson JS, König H, Lohr M, Edlund K, Botling J, Micke P, Nagase T. Noguchi S, et al. Clin Cancer Res. 2014 Sep 1;20(17):4660-72. doi: 10.1158/1078-0432.CCR-13-3328. Epub 2014 Jun 20. Clin Cancer Res. 2014. PMID: 24951773
Consistent mutation status within histologically heterogeneous lung cancer lesions.
Mattsson JS, Imgenberg-Kreuz J, Edlund K, Botling J, Micke P. Mattsson JS, et al. Histopathology. 2012 Oct;61(4):744-8. doi: 10.1111/j.1365-2559.2012.04245.x. Histopathology. 2012. PMID: 22458769
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P, Mattsson JS, Edlund K, Lohr M, Jirström K, Berglund A, Botling J, Rahnenfuehrer J, Marincevic M, Pontén F, Ekman S, Hengstler J, Wöll S, Sahin U, Türeci O. Micke P, et al. Int J Cancer. 2014 Nov 1;135(9):2206-14. doi: 10.1002/ijc.28857. Epub 2014 Apr 8. Int J Cancer. 2014. PMID: 24710653
An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M, Miyashita N, Mattsson JSM, Mikami Y, Sandelin M, Brunnström H, Micke P, Nagase T, Saito A. Horie M, et al. J Pathol. 2018 Oct;246(2):154-165. doi: 10.1002/path.5109. Epub 2018 Aug 13. J Pathol. 2018. PMID: 29876935
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Micke P, Botling J, Mattsson JSM, Planck M, Tran L, Vidarsdottir H, Nodin B, Jirström K, Brunnström H. Micke P, et al. Among authors: mattsson jsm. Sci Rep. 2019 Feb 4;9(1):1319. doi: 10.1038/s41598-018-37722-0. Sci Rep. 2019. PMID: 30718697 Free PMC article.
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.
Salomonsson A, Micke P, Mattsson JSM, La Fleur L, Isaksson J, Jönsson M, Nodin B, Botling J, Uhlén M, Jirström K, Staaf J, Planck M, Brunnström H. Salomonsson A, et al. Among authors: mattsson jsm. Cancer Med. 2020 Aug;9(15):5609-5619. doi: 10.1002/cam4.3149. Epub 2020 Jun 3. Cancer Med. 2020. PMID: 32491279 Free PMC article.
25 results
Jump to page